The University of Pittsburgh Medical Center (UPMC) has announced its investing in Health Fidelity, a San Mateo, Calif.-based company which produces analytics-based dashboards and other technologies that calculate risk for value-based healthcare initiatives.
The investment, for an undisclosed amount, comes after UPMC deployed Health Fidelity’s risk adjustment analytics platform for its health plan in 2014. The company plans to use the investment to introduce more risk adjustment and value-based software platforms to the market.
“By collaborating with the clinical and technology experts at UPMC, Health Fidelity is able to offer the most comprehensive, scalable solution on the market for perfecting the risk adjustment cycle,” stated Mary Beth Jenkins, senior vice president of UPMC Health Plan and UPMC WorkPartners. “It’s an innovative technology that has delivered measurable results to UPMC Health Plan, seamlessly integrating with existing risk adjustment processes to deliver results while improving compliance and process efficiencies.”
UPMC is no stranger to strategic investments. The organization has invested in other companies with which it had a previous relationship with, including Healthcare Informatics’ Up-and-Comer, Evolent Health. Evolent, which helps organizations manage populations with technology that was originally developed at UPMC, got $100 million from the organization as well as other investors.
